[{"Assets_0_Q3_USD":"6718662000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"9.02","EarningsPerShareBasic_3_Q3_USD":"40.04","EarningsPerShareDiluted_1_Q3_USD":"8.89","EarningsPerShareDiluted_3_Q3_USD":"39.5","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"180485000.0","NetIncomeLoss_1_Q3_USD":"269326000.0","NetIncomeLoss_3_Q3_USD":"1194143000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":"545138000.0","RevenuesConverted_3_Q3_USD":"1672568000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":"4900481000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"30292000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"30234000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"29863000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"29822000.0","filed":"20181105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"BIO-RAD LABORATORIES, INC.","period":"20180930","qtrs":"0","uom":"USD"}]